vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
for
Liver Cancer
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT05727787
Recruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
for
Cancer Pain, Visceral Pain, Gastrointestinal Neoplasms,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04907643
Recruiting
New
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
for
Hepatocellular Carcinoma (HCC)
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT07027436
Phase3, Recruiting
New
Defining the Ablative Dose for Y-90 TARE
for
HCC - Hepatocellular Carcinoma
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT07586046
Phase2, Recruiting
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06553885
Phase2, Recruiting
Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer
for
Liver Metastasis Colon Cancer
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18+
Code: NCT05314400
Recruiting
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05039632
Phase1, Phase2, Recruiting
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
for
Unresectable Hepatocellular Carcinoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05096715
Phase1, Recruiting
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma,
Location: San Francisco CA
Sponsor: Mary Feng, MD
Sex: All
Age: 18+
Code: NCT04430452
Phase2, Recruiting
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06541990
Recruiting
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma,
Location: New York NY, Richmond VA, Pittsburgh PA,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06600321
Phase1, Recruiting
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
for
Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic,
Location: Philadelphia PA, Palo Alto CA
Sponsor: Teclison Ltd.
Sex: All
Age: 20 - 70+
Code: NCT02174549
Phase1, Phase2, Recruiting
ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases